Stay updated on Nivolumab & Ipilimumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.

Latest updates to the Nivolumab & Ipilimumab in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a new revision tag (v3.5.3) replacing the previous v3.5.2, indicating a minor release or documentation update.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision banner updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedAn updated site revision label (Revision: v3.4.2) was added, and the previous funding notice and Revision: v3.4.1 deletion were removed; these are administrative changes unrelated to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedA site-wide notice about government funding was added, and the site version updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab & Ipilimumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ipilimumab in Melanoma Clinical Trial page.